Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CPA1 | P15085 | 1/20 | 0.31 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitric Acid SCHEMBL27553426 | 0.89 | CA5A (0.42) | CPA1BBOX1 | |
| SCHEMBL2240270 | 0.81 | BBOX1 (0.30) | BBOX1 | |
| Hydrogen Sulfide SCHEMBL28090943 | 0.80 | TSHR (0.33) | — | |
| Formic Acid SCHEMBL10338172 | 0.79 | BBOX1 (0.31) | BBOX1 | |
| SCHEMBL23277149 | 0.78 | BBOX1 (0.36) | MEN1KMT2ABBOX1 | |
| SCHEMBL1842151 | 0.78 | TSHR (0.39) | MEN1KMT2ABBOX1 | |
| SCHEMBL1263150 | 0.78 | BBOX1 (0.45) | MEN1KMT2ABBOX1 | |
| SCHEMBL596385 | 0.77 | TSHR (0.31) | — | |
| Lithium Ion SCHEMBL2504315 | 0.77 | TSHR (0.31) | — | |
| SCHEMBL5327324 | 0.77 | TSHR (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 307 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110988085-B | Chemical field effect transistor based on molecular receptor | 克莱米特有限责任公司 | 2023-07-04 | — | — | CN | claimed |
| EP-3381046-B1 | PROCESS FOR SELECTIVELY ETCHING P-DOPED POLYSILICON RELATIVE TO SILICON NITRIDE | ENTEGRIS INC (US) | 2022-12-28 | — | — | EP | claimed |
| US-10991809-B2 | Composition and process for selectively etching p-doped polysilicon relative to silicon nitride | ENTEGRIS, INC. (US) | 2021-04-27 | — | — | US | claimed |
| EP-3058359-B1 | METHOD FOR SECURING A MEMBRANE MATERIAL TO THE GATE OF A MOLECULAR RECEPTOR-BASED FIELD-EFFECT TRANSISTOR (CHEMFET) | SUPRASENSOR TECH LLC (US) | 2021-01-27 | — | — | EP | claimed |
| CN-110988085-A | Chemical field effect transistor based on molecular receptor | 苏普拉传感器技术有限责任公司 | 2020-04-10 | — | — | CN | claimed |
| CN-105960592-B | Chemical field effect transistor based on molecular receptor | 苏普拉传感器技术有限责任公司 | 2020-01-10 | — | — | CN | claimed |
| WO-2019002594-A1 | METHOD FOR SEPARATING CHROMATOGRAPHICALLY INDISTINGUISHABLE 2-AZIDO-1-NITRATES | SINUTRON KG (AT) | 2019-01-03 | — | — | WO | claimed |
| EP-3421480-A1 | METHOD FOR SEPARATING CHROMATOGRAPHICALLY INDISTINGUISHABLE AZIDONITRATES | Sinutron KG (AT) | 2019-01-02 | — | — | EP | claimed |
| US-20180337253-A1 | Composition and Process for Selectively Etching P-Doped Polysilicon Relative to Silicon Nitride | TRUIST BANK, AS NOTES COLLATERAL AGENT | 2018-11-22 | — | — | US | claimed |
| CN-104936697-B | Precalcining additive for mixed-metal oxides ammoxidation catalyst | 英尼奥斯欧洲股份公司 | 2018-11-16 | — | — | CN | claimed |
| EP-1558559-A1 | MANUFACTURING PROCESS FOR NO-DONATING COMPOUNDS SUCH AS NO-DONATING DICLOFENAC | Nicox S.A. (FR) | 2005-08-03 | — | — | EP | claimed |
| WO-2004026808-A1 | MANUFACTURING PROCESS FOR NO-DONATING COMPOUNDS SUCH AS NO-DONATING DICLOFENAC | NICOX SA. (FR) | 2004-04-01 | — | — | WO | claimed |
| US-6700008-B2 | USING CARBONYLATION CATALYST | GENERAL ELECTRIC COMPANY | 2004-03-02 | — | — | US | claimed |
| US-20030040428-A1 | Method and catalyst composition for producing aromatic carbonates | SHALYAEV KIRILL VLADIMIROVICH (US) | 2003-02-27 | — | — | US | claimed |
| US-20020119965-A1 | Nitriloxy derivatives of (R) and (S)-carnitine | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. | 2002-08-29 | — | — | US | claimed |
| US-6440893-B1 | GROUP 8, 9, OR 10 METAL SOURCE, INORGANIC COCATALYSTS OF GROUP 4 METAL SOURCE AND AT LEAST ONE GROUP 14 METAL SOURCE, AT LEAST ONE SALT COCATALYST ANION SELECTED FROM CARBOXYLATE, BENZOATE, ACETATE, SULFATE, NITRATE; FREE OF A HALIDE SOURCE | GENERAL ELECTRIC COMPANY | 2002-08-27 | — | — | US | claimed |
| US-6395923-B2 | ANTIISCHEMIC AGENTS; CARDIOVASCULAR DISORDERS | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2002-05-28 | — | — | US | claimed |
| US-20010011074-A1 | Nitriloxy derivatives of (R) and (S)-carnitine | SIGMA-TAU INDUSTRIES FARMACEUTICHE RIUNITE S.P.A. (IT) | 2001-08-02 | — | — | US | claimed |
| US-5321143-A | Reacting tartaric acid, ester or amide with thionyl chloride; cyclization, in situ oxidation | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1994-06-14 | — | — | US | claimed |
| CN-1068821-A | CHROMAN DERIVATIVES | NIPPON KAYAKU KK (JP) | 1993-02-10 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020119965-A1 | Nitriloxy derivatives of (R) and (S)-carnitine | CPT1B, CPT1A, CRAT | MEN1 4044/4885KMT2A 4068/4885CPA1 3199/4885 |
| US-20010011074-A1 | Nitriloxy derivatives of (R) and (S)-carnitine | SLC25A20, CRAT, CPT1A | MEN1 4079/4885KMT2A 3723/4885CPA1 2370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.